Home » Newsletters » BioWorld Science

BioWorld Science

March 17, 2008

View Archived Issues

Recent patent literature describes novel treatment options for diabetes

New compounds for treating HCV infection disclosed in recent patents

New therapeutic agents for respiratory disorders reported in recent patent literature

Novel antibiotic shows promising in vitro and in vivo activity against Gram-positive pathogens

Clinical Data initiates second of two phase III trials of vilazodone for depression

FDA to review Lev's BLA for Cinryze in hereditary angioedema

Glycotex completes enrollment in phase IIa study of GLYC-101 for wound healing

Cytopia presents an update on phase II, phase I and preclinical development of CYT-997

Oncolys and Tacere sign alliance and license agreement for Asia for HCV drug

Calando submits IND to FDA to initiate phase I clinical trial of CALAA-01 in cancer

Preclinical results of TRPV1 antagonist GRC-6211 reported

GSK's novel NOS-2 inhibitor SB-823387 shows analgesic efficacy in experimental dental pain

Preclinical profile of cis-ACCP, a novel MMP inhibitor with antimetastatic properties

FDA recommends approval of Amgen's BLA for romiplostim in immune thrombocytopenic purpura

Millennium announces publication of clinical results of phase I/II Velcade trial in multiple myeloma

Dosing initiated in obesity trial with oxyntomodulin analogue TKS-1225

Genentech to initiate three phase II clinical trials of GDC-0449 in 2008

Arana begins phase II trial for lead anti-TNF drug candidate

PregLem commences SAPHIR study for steroid sulfatase inhibitor PGL-2001

Raven initiates phase II RAV-12 trial in metastatic pancreatic cancer

Cardiome announces positive interim phase IIb results for oral vernakalant

Positive efficacy data from EndoTAG-1 phase II clinical trial in pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...